Wells Fargo & Company Cor Medix Inc. Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024

A detailed history of Wells Fargo & Company transactions in Cor Medix Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 30,421 shares of CRMD stock, worth $318,507. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,421
Previous 19,266 57.9%
Holding current value
$318,507
Previous $155,000 58.71%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$8.1 - $13.59 $90,355 - $151,596
11,155 Added 57.9%
30,421 $246,000
Q3 2024

Nov 13, 2024
SELL
$3.64 - $8.23 $786 - $1,777
-216 Reduced 1.11%
19,266 $155,000
Q2 2024

Aug 13, 2024
BUY
$4.08 - $6.39 $6,124 - $9,591
1,501 Added 8.35%
19,482 $84,000
Q1 2024

May 10, 2024
BUY
$2.94 - $4.24 $6,535 - $9,425
2,223 Added 14.11%
17,981 $76,000
Q4 2023

Feb 09, 2024
BUY
$3.0 - $4.01 $11,889 - $15,891
3,963 Added 33.6%
15,758 $59,000
Q3 2023

Nov 13, 2023
SELL
$3.6 - $4.46 $28,350 - $35,122
-7,875 Reduced 40.04%
11,795 $43,000
Q2 2023

Aug 15, 2023
BUY
$3.94 - $5.8 $71,782 - $105,670
18,219 Added 1255.62%
19,670 $77,000
Q1 2023

May 12, 2023
SELL
$3.22 - $4.61 $19,307 - $27,641
-5,996 Reduced 80.52%
1,451 $6,000
Q4 2022

Feb 13, 2023
BUY
$2.81 - $4.45 $22 - $35
8 Added 0.11%
7,447 $31,000
Q3 2022

Nov 14, 2022
BUY
$2.82 - $7.52 $16,959 - $45,225
6,014 Added 422.04%
7,439 $21,000
Q2 2022

Aug 12, 2022
SELL
$2.73 - $5.61 $21,067 - $43,292
-7,717 Reduced 84.41%
1,425 $5,000
Q1 2022

May 16, 2022
SELL
$3.83 - $6.24 $51,892 - $84,545
-13,549 Reduced 59.71%
9,142 $50,000
Q4 2021

Feb 14, 2022
BUY
$4.47 - $5.56 $98,205 - $122,153
21,970 Added 3047.16%
22,691 $104,000
Q3 2021

Nov 15, 2021
SELL
$4.46 - $7.11 $651 - $1,038
-146 Reduced 16.84%
721 $4,000
Q2 2021

Aug 16, 2021
SELL
$6.05 - $10.09 $64,474 - $107,529
-10,657 Reduced 92.48%
867 $5,000
Q1 2021

May 13, 2021
SELL
$6.84 - $17.58 $166,854 - $428,846
-24,394 Reduced 67.92%
11,524 $116,000
Q4 2020

Feb 09, 2021
BUY
$5.0 - $9.15 $46,605 - $85,287
9,321 Added 35.05%
35,918 $266,000
Q3 2020

Nov 05, 2020
SELL
$3.96 - $6.15 $21,875 - $33,972
-5,524 Reduced 17.2%
26,597 $160,000
Q2 2020

Aug 13, 2020
SELL
$3.08 - $6.56 $27,014 - $57,537
-8,771 Reduced 21.45%
32,121 $202,000
Q1 2020

May 14, 2020
BUY
$2.35 - $7.08 $96,096 - $289,515
40,892 New
40,892 $147,000

Others Institutions Holding CRMD

# of Institutions
135
Shares Held
21.9M
Call Options Held
599K
Put Options Held
401K
View Full List

About CorMedix Inc.

CRMD Quotes by TradingView
  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $431M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email